SCHEMBL3248499

SCHEMBL3248499

O=CC(Br)c1cc(C(F)(F)F)ccc1Cl

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PDE2A O00408 3/20 0.42
MCL1 Q07820 6/20 0.39
HTR2A P28223 1/20 0.37
SLC6A4 P31645 1/20 0.37
KCNH2 Q12809 1/20 0.37
KMT2A Q03164 2/20 0.37
MEN1 O00255 1/20 0.37
ALDH1A1 P00352 1/20 0.37
TSHR P16473 1/20 0.37
ATM Q13315 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
GSK3B P49841 1/20 0.35
JAK2 O60674 1/20 0.35
JAK1 P23458 1/20 0.35
TYK2 P29597 1/20 0.35
LMNA P02545 1/20 0.35
AHR P35869 1/20 0.34
CHRNA7 P36544 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5608722 0.81 IDO1 (0.43) PDE2AKMT2AMEN1TSHRGSK3B
SCHEMBL6446889 0.81 CES2 (0.43) PDE2AALDH1A1GSK3B
SCHEMBL6448282 0.80 PDE2A (0.36) PDE2AMCL1KMT2AMEN1GSK3B
SCHEMBL27643682 0.80 PDE2A (0.50) PDE2AMCL1HTR2ASLC6A4KCNH2
SCHEMBL27624244 0.80 PDE2A (0.40) PDE2AMCL1HTR2ASLC6A4KCNH2
SCHEMBL6472594 0.79 PSEN1 (0.35) HTR2ASLC6A4KCNH2ALDH1A1JAK2
SCHEMBL4963648 0.78 PDE2A (0.51) PDE2AGSK3B
SCHEMBL20551557 0.78 PDE2A (0.51) PDE2AGSK3B
SCHEMBL27703906 0.77 PDE2A (0.54) PDE2AMCL1HTR2ASLC6A4KCNH2
SCHEMBL18932351 0.77 PDE2A (0.46) PDE2AMCL1HTR2ASLC6A4KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2190844-A2 IMIDAZO[L,2-a]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2010-06-02 EP disclosed
WO-2009023253-A2 IMIDAZO[L,2-α]PYRIDINE DERIVATIVES AS MODULATORS OF THE 5-HT2A SEROTONIN RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS INC. (US) 2009-02-19 WO disclosed
EP-1749002-A1 PYRROLE OR IMIDAZOLE AMIDES FOR TREATING OBESITY F.HOFFMANN-LA ROCHE AG (CH) 2007-02-07 EP disclosed
WO-2005108393-A1 PYRROLE OR IMIDAZOLE AMIDES FOR TREATING OBESITY F. HOFFMANN-LA ROCHE AG (CH) 2005-11-17 WO disclosed
EP-1583742-A1 NOVEL CB 1 RECEPTOUR INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2005-10-12 EP disclosed
WO-2004060870-A1 NOVEL CB 1 RECEPTOUR INVERSE AGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2004-07-22 WO disclosed